{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "exchange": "STO", "shortName": "Klaria Pharma Holding AB", "longName": "Klaria Pharma Holding AB (publ.)", "messageBoardId": "finmb_290845813", "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "se_market", "esgPopulated": false, "regularMarketChangePercent": -12.321429, "regularMarketPrice": 0.491, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.89326084, "fiftyTwoWeekLow": 0.45, "fiftyTwoWeekHigh": 4.6, "earningsTimestamp": 1621594740, "earningsTimestampStart": 1621594740, "earningsTimestampEnd": 1621594740, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.95, "epsForward": -0.2, "epsCurrentYear": -0.1, "priceEpsCurrentYear": -4.91, "sharesOutstanding": 106501000, "bookValue": 0.971, "fiftyDayAverage": 0.69776, "fiftyDayAverageChange": -0.20675999, "fiftyDayAverageChangePercent": -0.29631963, "twoHundredDayAverage": 1.8651714, "twoHundredDayAverageChange": -1.3741715, "twoHundredDayAverageChangePercent": -0.73675346, "marketCap": 57894300, "forwardPE": -2.455, "priceToBook": 0.5056642, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": -0.069000006, "regularMarketTime": 1684142202, "regularMarketDayHigh": 0.56, "regularMarketDayRange": "0.491 - 0.56", "regularMarketDayLow": 0.491, "regularMarketVolume": 184604, "regularMarketPreviousClose": 0.56, "bid": 0.5, "ask": 0.516, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 0.56, "averageDailyVolume3Month": 104843, "averageDailyVolume10Day": 107129, "fiftyTwoWeekLowChange": 0.04100001, "fiftyTwoWeekLowChangePercent": 0.09111113, "fiftyTwoWeekRange": "0.45 - 4.6", "fiftyTwoWeekHighChange": -4.1089997, "firstTradeDateMilliseconds": 1445410800000, "symbol": "KLAR.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Virdings All\u00e9 2", "city": "Uppsala", "zip": "754 50", "country": "Sweden", "phone": "46 84 46 42 99", "website": "https://www.klaria.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company in Sweden and internationally. It offers Sumatriptan for the treatment of migraine; and Midazolam for acute epilepsy. The company's clinical phase products include Epinephrine/Adrenaline for the treatment of acute allergic reaction; Naloxone for opioid overdose; and Ketamine for acute pain and depression. It also focuses on the commercialization of cannabis/cannabinoids, including THC and CBD for medical and recreational applications. The company was founded in 2014 and is based in Uppsala, Sweden.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jesper  Wiklund", "age": 53, "title": "Chief Exec. Officer", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 2834000, "fmt": "2.83M", "longFmt": "2,834,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Scott  Boyer", "age": 60, "title": "Chief Scientific Officer & Director", "yearBorn": 1962, "fiscalYear": 2022, "totalPay": {"raw": 1876000, "fmt": "1.88M", "longFmt": "1,876,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hans  Richter", "age": 73, "title": "Chief Financial Officer on Consultative", "yearBorn": 1949, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Susan  Suchdev", "age": 50, "title": "Chief Operating Officer", "yearBorn": 1972, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Marc  Willuhn Ph.D.", "age": 53, "title": "Head of Chemistry, Manufacturing & Control", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Hans  Olivecrona M.D., Ph.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1958, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}